http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110507620-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
filingDate 2019-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110507620-B
titleOfInvention A kind of compound glucosamine sulfate dispersible tablet and preparation method thereof
abstract The invention belongs to the field of medicine and discloses a compound glucosamine sulfate dispersible tablet and a preparation method thereof. The compound glucosamine sulfate dispersible tablet of the present invention comprises glucosamine sulfate sodium chloride double salt, chondroitin sulfate, disintegrant, magnesium stearate, polyvinyl alcohol, dextrin and ethanol. The dispersible tablet comprises active ingredients glucosamine sulfate, chondroitin sulfate, pharmaceutically acceptable disintegrant, and binder in a pharmaceutically effective amount, and is mixed with crospovidone and sodium carboxymethyl starch by glucosamine sulfate and polyvinyl alcohol. , After dextrin is used as a binder for granulation, the hygroscopicity is greatly reduced, the stability of the product is enhanced, and the dissolution is rapid.
priorityDate 2019-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526588
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID469617
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID380561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID525072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453894100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712569
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30554
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID559087
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5321
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID480048
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396394
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100145731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45357623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553

Total number of triples: 51.